Problem: Some continuous electronic fetal monitoring (CEFM) devices restrict women's bodily autonomy by limiting their mobility in labour and birth.
Elsevier,

Med, Volume 2, 15 January 2021

Despite the centrality of skin in the field, dermatology remains among the least racially diverse specialties in American medicine. In fact, even the main textbooks used in educating dermatologists lack adequate representation of clinical images of disease in people with skin of color.
Lack of Black Physicians and Scientists.
Immune response and inflammation in cancer health disparities.
Elsevier, Alzheimer’s Disease: Understanding Biomarkers, Big Data, and Therapy, Volume , 1 January 2021
In the next 30 years, Alzheimer’s disease cases are predicted to drastically increase.
This article ties to SDG 3. In this study, time-varying associations of pre-migration and post-migration stressors in refugees' mental health were explored. Understanding these time-varying association could help in designing tailored health promotion services at different resettlement stages and improving the efficiency of resource allocation.
Graphical abstract
Proteasome function is impaired in Alzheimer's disease (AD). Proteasome activation is followed by a decrease in amyloid-beta (Aβ) load. A reduced amount of Aβ correlates with significantly improved behavior and frailty level. Proteasome activation represents a promising intervention for alleviating AD pathology.
This Article supports SDG 3 by summarising global, regional, and national estimates of the burden of tracheal, bronchus, and lung cancer and larynx cancer and their attributable risks from 1990 to 2019, and highlighting the importance of preventive measures such as smoking control interventions, air quality management programmes focused on major air pollution sources, and widespread access to clean energy.
Graphical abstract of article
Laughter therapy is a universal non-pharmacologic approach to reduce stress and anxiety. Laughter therapy can be used during COVID-19 pandemic as a useful supplementary therapy to reduce the mental health burden.
Women represent ⅔ of the cases of Alzheimer's disease (AD). Current research has focused on differential risks to explain higher rates of AD in women.

Pages